These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23859472)

  • 1. A review of the possible mechanisms of action of tocotrienol - a potential antiosteoporotic agent.
    Chin KY; Mo H; Soelaiman IN
    Curr Drug Targets; 2013 Dec; 14(13):1533-41. PubMed ID: 23859472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocotrienol as a Protecting Agent against Glucocorticoid-Induced Osteoporosis: A Mini Review of Potential Mechanisms.
    Ekeuku SO; Mohd Ramli ES; Abdullah Sani N; Abd Ghafar N; Soelaiman IN; Chin KY
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mevalonate-suppressive dietary isoprenoids for bone health.
    Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
    J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim.
    Xue L; Jiang Y; Han T; Zhang N; Qin L; Xin H; Zhang Q
    J Ethnopharmacol; 2016 Nov; 192():370-381. PubMed ID: 27422162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
    Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
    J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Potential Therapeutics for Osteoporosis by Exploiting the Relationship between Mevalonate Pathway and Bone Metabolism.
    Hasan WNW; Chin KY; Jolly JJ; Ghafar NA; Soelaiman IN
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):450-457. PubMed ID: 29683099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annatto tocotrienol improves indices of bone static histomorphometry in osteoporosis due to testosterone deficiency in rats.
    Chin KY; Abdul-Majeed S; Fozi NF; Ima-Nirwana S
    Nutrients; 2014 Nov; 6(11):4974-83. PubMed ID: 25389899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Tocotrienol on Bone Peptides in a Rat Model of Osteoporosis Induced by Metabolic Syndrome: The Possible Communication between Bone Cells.
    Wong SK; Chin KY; Ima-Nirwana S
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31505801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Tocotrienol in Preventing Male Osteoporosis-A Review of Current Evidence.
    Chin KY; Ima-Nirwana S
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological effects of tocotrienol on bone: a review on evidence from rodent models.
    Chin KY; Ima-Nirwana S
    Drug Des Devel Ther; 2015; 9():2049-61. PubMed ID: 25897211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical Model of Bone Remodeling Captures the Antiresorptive and Anabolic Actions of Various Therapies.
    Ross DS; Mehta K; Cabal A
    Bull Math Biol; 2017 Jan; 79(1):117-142. PubMed ID: 27905067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tocotrienol from Bixa orellana (annatto) on bone histomorphometry in a male osteoporosis model induced by buserelin.
    Mohamad NV; Soelaiman IN; Chin KY
    Biomed Pharmacother; 2018 Jul; 103():453-462. PubMed ID: 29674281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation].
    Kitao T; Ito Y; Fukui M; Yamamoto M; Shoji Y; Takeda S; Shirahase H
    Yakugaku Zasshi; 2019; 139(1):19-25. PubMed ID: 30606923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stimulatory impact of d-δ-Tocotrienol on the differentiation of murine MC3T3-E1 preosteoblasts.
    Shah AK; Yeganehjoo H
    Mol Cell Biochem; 2019 Dec; 462(1-2):173-183. PubMed ID: 31620952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?].
    Neumann E
    Z Rheumatol; 2006 Sep; 65(5):400, 402-6. PubMed ID: 16924451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitargeted combination effects of a triherbal formulation containing ELP against osteoporosis: in vitro evidence.
    Ko CH; Lau KM; Chau L; Cheung DW; Siu WS; Wong HL; Shum WT; Gao S; Fung KP; Leung PC; Poon SK; Lau CB
    J Pharm Pharmacol; 2016 Jun; 68(6):826-33. PubMed ID: 27019348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocotrienol and Its Role in Chronic Diseases.
    Chin KY; Pang KL; Soelaiman IN
    Adv Exp Med Biol; 2016; 928():97-130. PubMed ID: 27671814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/β-catenin signalling pathway.
    Du L; Nong MN; Zhao JM; Peng XM; Zong SH; Zeng GF
    Sci Rep; 2016 Aug; 6():32261. PubMed ID: 27554324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone.
    Ahmad NS; Khalid BA; Luke DA; Ima Nirwana S
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):761-70. PubMed ID: 16173934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiosteoporotic Effects of
    Kuriya K; Nishio M; Wada S; Katsuzaki H; Nishise M; Okamoto H; Umekawa H
    J Med Food; 2019 Apr; 22(4):365-373. PubMed ID: 30785809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.